Abstract
Presentation given by William Gruber, Senior Vice President Vaccine Clinical R&D Pfizer for the ACIP emergency meeting of December 11th.
- Background paper
- Americas
- United States of America
- vaccine safety
- vaccine efficacy
- Reactogenicity
- COVID-19
